YK is an ovarian cancer-specific and effective traditional Tibetan formulation bearing the following anticancer properties: (i) imposes G1 arrest of cells by activating p53, (ii) induces cytochrome c release from mitochondria, and (iii) inhibits angiogenesis. This evidence concerns the gene CYCS and ovarian carcinoma.